Biolase (BIOL) Reports Q4 EPS of ($0.03)

Biolase (NASDAQ: BIOL) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $11.97 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'